The Venture Codex Logo

The Venture Codex

Pathway BioVentures

30 S. Wacker Drive Suite 2500, Chicago, IL, 60606, United States

Overview

Seed-stage life sciences fund investing in next-generation therapeutics.

Founded

2018

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Health Care
Life Science
Medical Device
...

Investment portfolio

4rounds
NAMEDATESIZE
Cytospire Therapeutics
May 2026Participated
$83 MSeries A
Axonis Therapeutics
Oct 2024Participated
$115 MSeries A
Modifi Bio
Oct 2023Participated
$4 MSeed
miRecule
May 2021Participated
$6 MSeed
Cytospire Therapeutics
May 2026Participated
$83 MSeries A
Axonis Therapeutics
Oct 2024Participated
$115 MSeries A
Modifi Bio
Oct 2023Participated
$4 MSeed
miRecule
May 2021Participated
$6 MSeed
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Pathway BioVentures: 4 funding rounds are recorded in the selected participation categories.All available history.
Pathway BioVentures: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A02

Monthly Deal Activity

Pathway BioVentures: 4 deals are recorded across 66 months.All available history.
Pathway BioVentures: 4 deals are recorded across 66 months. All available history
MonthDeals
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Pathway BioVentures: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Pathway BioVentures: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4

Deal Size Distribution

Pathway BioVentures: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Pathway BioVentures: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M1
$10M-$25M0
$25M-$50M0
$50M-$100M1
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Pathway BioVentures: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Pathway BioVentures: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Europe1
Pathway BioVentures: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Pathway BioVentures: 20 co-investors are shown, with Alexandria Venture Investments sharing 2 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments2
4BIO Capital1
Abingworth1
Advantage Capital1
Alumni Ventures1
Boutique Venture Partners1
BoxOne Ventures1
BrightEdge1
British Business Bank1
Connecticut Innovations1
Cormorant Asset Management1
Criteria Bio Ventures1
Eos Bioinnovation1
FSHD Society1
Hatteras Venture Partners1
HighCape Capital1
Iaso Ventures1
LifeArc1
Lumira Ventures1
Maryland Momentum Fund1

Investment Strategy

Pathway BioVentures: Led accounts for 0% and participating for 100% of round participation.All available history.
Pathway BioVentures: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating4100%
Pathway BioVentures: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Pathway BioVentures: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Daniel Jacobs

Founder & Managing Director

Jacob Segil

Venture Advisor

Matt Martin

Venture Partner